INR 104.92
(1.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 95.71 Million INR | 37.64% |
2022 | 69.54 Million INR | -15.17% |
2021 | 81.98 Million INR | 90.38% |
2020 | 43.06 Million INR | -36.04% |
2019 | 67.32 Million INR | -3.85% |
2018 | 70.02 Million INR | -37.46% |
2017 | 111.96 Million INR | -15.44% |
2016 | 132.4 Million INR | 22.47% |
2015 | 108.11 Million INR | -43.82% |
2014 | 192.45 Million INR | 21.58% |
2013 | 158.29 Million INR | -12.42% |
2012 | 180.74 Million INR | 12.41% |
2011 | 160.78 Million INR | 14.67% |
2010 | 140.21 Million INR | 11.84% |
2009 | 125.37 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q2 | 79.83 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 95.71 Million INR | 37.64% |
2023 Q4 | 95.71 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 70.21 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 69.54 Million INR | -15.17% |
2022 Q4 | 69.54 Million INR | 0.0% |
2021 FY | 81.98 Million INR | 90.38% |
2021 Q2 | 82.32 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 81.98 Million INR | 0.0% |
2020 Q4 | 43.06 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 51.02 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 43.06 Million INR | -36.04% |
2019 Q4 | 67.32 Million INR | 0.0% |
2019 FY | 67.32 Million INR | -3.85% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 95.44 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q1 | - INR | 0.0% |
2018 FY | 70.02 Million INR | -37.46% |
2018 Q4 | 70.02 Million INR | 0.0% |
2017 FY | 111.96 Million INR | -15.44% |
2016 Q4 | 132.4 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2016 Q2 | 125.44 Million INR | 0.0% |
2016 FY | 132.4 Million INR | 22.47% |
2016 Q3 | - INR | -100.0% |
2015 FY | 108.11 Million INR | -43.82% |
2015 Q2 | 125.72 Million INR | 0.0% |
2015 Q4 | 108.11 Million INR | -14.01% |
2015 Q1 | - INR | -100.0% |
2015 Q3 | 125.72 Million INR | 0.0% |
2014 Q4 | 192.45 Million INR | 0.0% |
2014 Q1 | 158.3 Million INR | 0.0% |
2014 FY | 192.45 Million INR | 21.58% |
2013 Q3 | - INR | -100.0% |
2013 Q1 | 180.74 Million INR | 0.0% |
2013 FY | 158.29 Million INR | -12.42% |
2013 Q2 | 128.86 Million INR | -28.7% |
2012 Q4 | 180.74 Million INR | 0.0% |
2012 FY | 180.74 Million INR | 12.41% |
2012 Q3 | - INR | -100.0% |
2012 Q2 | 145.88 Million INR | 0.0% |
2011 FY | 160.78 Million INR | 14.67% |
2010 FY | 140.21 Million INR | 11.84% |
2009 FY | 125.37 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Biocon Limited | 49.43 Billion INR | 99.806% |
Blue Jet Healthcare Limited | 1.29 Billion INR | 92.628% |
Concord Biotech Limited | 2.07 Billion INR | 95.397% |
Dishman Carbogen Amcis Limited | 8.82 Billion INR | 98.916% |
Jubilant Ingrevia Limited | 9.41 Billion INR | 98.983% |
Panacea Biotec Limited | 1.77 Billion INR | 94.621% |
Piramal Pharma Limited | 21.75 Billion INR | 99.56% |
SMS Lifesciences India Limited | 812.1 Million INR | 88.214% |
Supriya Lifescience Limited | 852.49 Million INR | 88.772% |
Syngene International Limited | 2.38 Billion INR | 95.987% |
TAKE Solutions Limited | 7.96 Million INR | -1102.487% |
Zota Health Care Limited | 537.66 Million INR | 82.197% |